Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that female pattern hair loss is linked to psychological distress and is hard to diagnose and treat, with its causes still not fully understood.

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

TrichoScan® is a reliable tool for measuring hair growth, providing quicker and more consistent results than manual methods.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Smoking and drinking worsened hair loss in men with genetic hair loss, while eating and sleeping habits didn't; genetics played a bigger role than environment in hair loss.

ESR2 gene linked to female-pattern hair loss.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Trichoscopic measurements help determine the severity of female pattern hair loss.

Female pattern hair loss does not significantly affect sexual dysfunction.

Trichoscopy helps diagnose and monitor hair loss, showing different signs at various stages of hair thinning.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Injections improve hair growth, density, and thickness in women safely.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Both methods improve hair density and thickness; double-spin may be more effective.

IFHUT shows better hair growth than FUE, but needs improvements in positioning, speed, and accuracy.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.